For many people fighting cancer, the battle is fought on two fronts: the invisible struggle against the disease and the visible transformation of the body. Among the most distressing side effects of chemotherapy and targeted therapies is hair loss, a change that often feels like a public stripping of identity and a constant reminder of illness.
In a desperate search to reclaim their appearance, many patients turn to biotin—a B-vitamin widely marketed as a miracle cure for thinning hair and brittle nails. Sold in nearly every pharmacy and promoted across social media, these supplements are often viewed as harmless “wellness” additions. However, medical experts are now warning that this popular vitamin may be doing more than just failing to grow hair; it could be quietly sabotaging life-saving cancer care.
The danger isn’t that biotin is toxic, but that it is a “biochemical mimic.” In the laboratory, biotin can interfere with the assays used to monitor cancer recurrence and organ function. This interference can lead to inaccurate blood test results, which in turn may lead doctors to believe a patient is doing better—or worse—than they actually are, potentially delaying critical treatment or masking a returning malignancy.
Dr. Brittany Dulmage, an oncodermatologist at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, sees this trend frequently in her clinic. According to Dulmage, more than half of her patients seeking help for hair loss are taking supplements they started on their own, often guided by online forums or word-of-mouth rather than clinical evidence.
The Illusion of the Harmless Supplement
Biotin, also known as vitamin B7, plays a legitimate role in the body by helping produce keratin, the protein that forms the structural basis of hair and nails. Because it is abundant in a standard diet—found in eggs, nuts, seeds, whole grains, and dairy—true biotin deficiency is exceedingly rare in the general population.
The problem arises when patients take high-dose supplements. Because these products are categorized as dietary supplements rather than drugs, they are not subject to the same rigorous FDA oversight regarding efficacy. There is little to no scientific evidence that oral biotin supplements actually accelerate hair regrowth in patients recovering from cancer treatment.
“People have the misconception that biotin supplements are harmless and there’s no reason not to take them,” says Dr. Dulmage. “The reality is that the supplements may cause inaccurate lab results, resulting in a delay or change in patients’ treatment plans.”
How Biotin Distorts Critical Lab Work
To understand how a vitamin can “trick” a lab test, one must look at the chemistry of the assay. Many modern blood tests rely on a streptavidin-biotin binding system to detect specific hormones or proteins. When a patient has an excess of biotin in their system, the supplement competes with the test’s reagents, distorting the final reading.
This interference does not change the actual hormone levels in the patient’s body, but it changes how the machine reads those levels. Depending on the type of test, the result can be falsely elevated or falsely suppressed, creating a dangerous “blind spot” for the oncology team.
| Test Type | Common Use | Biotin’s Potential Effect | Clinical Risk |
|---|---|---|---|
| PSA / TSH | Prostate & Thyroid Monitoring | Falsely Lowered | Masking cancer recurrence |
| Estrogen / Testosterone | Hormonal Therapy Monitoring | Falsely Elevated | Delayed or unnecessary therapy changes |
| Troponin | Heart Attack Detection | Inaccurate Reading | Delayed diagnosis of cardiac event |
For a cancer survivor, a falsely low PSA (prostate-specific antigen) or TSH (thyroid-stimulating hormone) level could be catastrophic, as it may suggest the cancer is in remission when it is actually returning.
A Patient’s Warning: When Results Don’t Match Reality
Anna Malagoli of Columbus experienced this confusion firsthand. After her breast cancer went into remission, she struggled with the emotional toll of her changed appearance and began taking high doses of biotin to restore her long, curly hair.
“Your hair is particularly much a part of you,” Malagoli recalls. “The amount of information on the internet can lead you in different directions. I was taking so much biotin it’s not even funny.”
The red flag appeared when her lab results began to shift in ways that didn’t align with her physical symptoms. It was only during a consultation with Dr. Dulmage that the connection was made. Malagoli notes that throughout her journey, no one had warned her that a simple vitamin could interfere with the very tests designed to keep her safe.
Evidence-Based Alternatives for Hair Recovery
For patients eager to regain their hair, Dr. Dulmage recommends moving away from oral supplements and toward FDA-approved topical treatments. Minoxidil, available over-the-counter in foams and lotions, is considered a safer and more effective option for many, as it does not enter the bloodstream in quantities that interfere with lab assays.
For those who insist on continuing biotin, Dr. Dulmage advises a strict “washout” period: stopping the supplement at least 72 hours before any scheduled blood work.
However, this strategy is not foolproof. Some of the most critical tests—such as those for troponin, used to diagnose a heart attack in an emergency room—are unplanned. In an emergency, a physician may not know a patient is taking biotin, leading to a misdiagnosis of a cardiac event.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with your treating physician or oncologist before starting or stopping any supplement or medication.
To address this gap in care, Dr. Dulmage recently authored a paper in JCO Oncology Practice, urging oncologists to be more proactive in discussing hair loss with their patients. By acknowledging the emotional weight of alopecia and providing safe, evidence-based alternatives, providers can prevent patients from turning to potentially disruptive supplements.
As personalized medicine continues to evolve, the focus is shifting toward a more holistic view of patient care—one where the desire to feel “normal” again is supported by clinical safety. The next step for many oncology clinics is the implementation of standardized screening questions regarding supplement use during every routine blood draw to ensure that no “invisible” vitamin stands in the way of an accurate diagnosis.
Do you or a loved one use supplements during cancer recovery? Share your experience in the comments or share this article to help other patients stay informed.
